Iron overload resulting from the chronic oral administration of ferric citrate induces parkinsonism phenotypes in middle-aged mice

Aging (Albany NY). 2019 Nov 7;11(21):9846-9861. doi: 10.18632/aging.102433. Epub 2019 Nov 7.

Abstract

Iron homeostasis is critical for maintaining normal brain physiological functions, and its mis-regulation can cause neurotoxicity and play a part in the development of many neurodegenerative disorders. The high incidence of iron deficiency makes iron supplementation a trend, and ferric citrate is a commonly used iron supplement. In this study, we found that the chronic oral administration of ferric citrate (2.5 mg/day and 10 mg/day) for 16 weeks selectively induced iron accumulation in the corpus striatum (CPu), substantia nigra (SN) and hippocampus, which typically caused parkinsonism phenotypes in middle-aged mice. Histopathological analysis showed that apoptosis- and oxidative stress-mediated neurodegeneration and dopaminergic neuronal loss occurred in the brain, and behavioral tests showed that defects in the locomotor and cognitive functions of these mice developed. Our research provides a new perspective for ferric citrate as a food additive or in clinical applications and suggests a new potential approach to develop animal models for Parkinson's disease (PD).

Keywords: ferric citrate; iron; neurodegeneration; oxidative stress; parkinson’s disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / metabolism*
  • Brain / pathology
  • Disease Models, Animal
  • Ferric Compounds / administration & dosage
  • Ferric Compounds / adverse effects*
  • Ferric Compounds / metabolism
  • Iron Overload / chemically induced*
  • Iron Overload / pathology
  • Male
  • Mice
  • Oxidative Stress
  • Parkinsonian Disorders / chemically induced*
  • Parkinsonian Disorders / pathology

Substances

  • Ferric Compounds
  • ferric citrate